Tim discussed the FIFA anticorruption indictments on the TRT World News Istanbul newscast, and explained the implications for FIFA officials under US law.
In today’s environment, companies are routinely in the government’s crosshairs. Steve Feldman and Tim Peterson spoke at the Forensic Accounting and Litigation Services Conference of the New York Society of CPAs on best practices for dealing with government investigations.
Tim participated as a panelist discussing FCPA and anticorruption in pharmaceuticals and life sciences at the American Conference Institute (ACI) 10th Advanced Conference on FCPA & Anti-Corruption for the Life Sciences Industry. U.S. and international enforcement authorities have continued their vigorous pursuit of life sciences companies for FCPA and anti-corruption violations, resulting in recent high profile investigations across the globe and heightened government compliance expectations. ACI’s conference provides a forum for the key players - top federal prosecutors, preeminent corporate counsel, and leading FCPA practitioners - to come together for critical networking and benchmarking on how to combat the next wave of global anti-corruption risk factors confronting the industry.
It has been a year since the DOJ and SEC released their long-awaited guidance on the FCPA, “A Resource Guide to the U.S. Foreign Corrupt Practices Act.” The guidance provided user-friendly insight into how the government approaches FCPA enforcement, and set forth a number of factors companies should consider in evaluating their anti-corruption compliance programs and procedures.
Rob Park and Tim Peterson discuss the long-awaited and recently released guidance from the Department of Justice and the Securities and Exchange Commission Division of Enforcement on the FCPA.